Skip to main content
SpringerLink
Log in

Vascular Function

  • Chapter
Essential Cardiology

  • 2032 Accesses

Abstract

All blood vessels have an outer adventitia, a medial layer of smooth muscle cells, and an intima lined by endothelial cells. Contraction of the vascular smooth muscle causes changes in the diameter and wall tension of blood vessels. In the aorta and large arteries vascular smooth muscle contraction affects mainly the compliance (the reciprocal of stiffness) of the vessel. At the precapillary level, contraction of vascular smooth muscle will regulate blood flow to different organs, and contribute to the peripheral resistance. Compliance of large vessels and resistance of arterioles both contribute most of the impedance of the vascular circuit and therefore the afterload of the heart. The capacity of the circulation is determined by the degree of contraction of the veins (“capacitance vessels”) especially in the splanchnic area; this will affect the venous filling pressure, or preload, of the heart.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995;268:C799–C822.

    PubMed  CAS  Google Scholar 

  2. Lijnen P. Alterations in sodium metabolism as an etiological model for hypertension. Cardiovasc Drugs Ther 1995;9:377–399.

    Article  PubMed  CAS  Google Scholar 

  3. Stamler JS, Dzau VJ, Loscalzo J. The vascular smooth muscle cell. In: Loscalzo J, Creager MA, Dzau VJ, eds. Vascular Medicine: A Textbook of Vascular Biology and Diseases, 1st ed. Little Brown, Boston, 1992, pp. 79–132.

    Google Scholar 

  4. Insel PA. Adrenergic receptors: evolving concepts and clinical applications. N Engl J Med 1996;334:580–585.

    Article  PubMed  CAS  Google Scholar 

  5. Day MD. Autonomic Pharmacology, Experimental and Clinical Aspects. Churchill Livingstone, Edinburgh, 1979.

    Google Scholar 

  6. Alexander SPH, Peters JA. Receptor and Ion Channel Nomenclature Supplement. 12th ed. TIPS 2001, pp. 9–13.

    Google Scholar 

  7. Rosendorff C. The renin-angiotensin system and vascular hypertrophy. JACC 1996;28:803–812.

    PubMed  CAS  Google Scholar 

  8. Rosendorff C. Vascular hypertrophy in hypertension. Role of the renin-angiotensin system. Mt Sinai J Med 1998;65:108–117.

    PubMed  CAS  Google Scholar 

  9. Atlas SA, Rosendorff C. The renin-angiotensin system-from Tigerstedt to Goldblatt to ACE inhibition and beyond. Mt Sinai J Med 1998;65:81–86.

    PubMed  CAS  Google Scholar 

  10. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639–672.

    PubMed  CAS  Google Scholar 

  11. Horiuchi M, Akashita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999;33:613–621.

    PubMed  CAS  Google Scholar 

  12. Rosendorff C. Endothelin, vascular hypertrophy and hypertension. Cardiovasc Drugs Ther 1996;10:795–802.

    Article  Google Scholar 

  13. Schiffrin EL. Role of endothelin-1 in hypertension. Hypertension 1999;34(Part 2):876–881.

    PubMed  CAS  Google Scholar 

  14. Lloyd-Jones DM, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 1996;47:365–375.

    Article  PubMed  CAS  Google Scholar 

  15. Radomski MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function. In: Authi KS, ed. Mechanisms of Platelet Activation and Control. Plenum, New York, 1993, pp. 251–264.

    Google Scholar 

  16. Vanhoutte PM. Endothlial function and vascular disease. In: Panza JA, Cannon RO III, eds. Endothelium, Nitric Oxide and Atherosclerosis. From Basic Mechanisms to Clinical Implications. Futura Publishing, New York, 1999, pp. 79–95.

    Google Scholar 

  17. Lefkowitz RJ, Hoffman BB, Taylor P. Neurohumoral transmission: the autonomic and somatic motor nervous systems. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. The Pharmacologic Basis of Therapeutics, 8th ed. Pergamon Press, New York, 1992, pp. 84–121.

    Google Scholar 

  18. Hollenberg N. Serotonin and vascular responses. Ann Rev Pharmacol Toxicol 1988;28:41–59.

    Article  CAS  Google Scholar 

  19. Olah ME, Stiles GL. Adenosine receptor subtypes: characterization and receptor regulation. Annu Rev Pharmacol Toxicol 1995;35:581–606.

    Article  PubMed  CAS  Google Scholar 

  20. Peng YJ, Gong QL, Li P. GABA (A) receptors in the rostral ventrolateral medulla mediate the depressor response induced by stimulation of the greater splanchnic nerve afferent fibres in rats. Neurosci Lett 1998;249:95–98.

    Article  PubMed  CAS  Google Scholar 

  21. Schoner W. Endogenous cardiotonic steroids. Cell Mol Biol 2001;47(2):273–280.

    PubMed  CAS  Google Scholar 

  22. Nasjletti A. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension 1997;31:194–200.

    Google Scholar 

  23. Nasjletti A, McGiff JC. Prostaglandins and P450 metabolites. In: Izzo JL, Black HR, eds. Hypertension Primer, 3rd ed. American Heart Association and Lippincott Williams & Wilkins, Philadelphia, 2003, pp. 55–58.

    Google Scholar 

  24. Margolius HS. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension 1995;26(2):221–229.

    PubMed  CAS  Google Scholar 

  25. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321–328.

    Article  PubMed  CAS  Google Scholar 

  26. Cowley AW Jr, Michalkiewicz M. Vasopressin and neuropeptide Y. In: Izzo JL, Black HR, eds. Hypertension Primer, 3rd ed. American Heart Association and Lippincott Williams & Wilkins, Philadelphia, 2003, pp. 37–39.

    Google Scholar 

  27. Michel MC, Rascher W. Neuropeptide Y: a possible role in hypertension. J Hypertens 1995;13:385–395.

    Article  PubMed  CAS  Google Scholar 

  28. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327–333.

    Article  PubMed  CAS  Google Scholar 

  29. Vaughn DE. Plasminogen activator inhibitor-1: a common denominator in cardiovascular disease. J Invest Med 1998;46:370–376.

    Google Scholar 

  30. Bishop-Bailey D. Peroxisome proliferator-actived receptors in the cardiovascular system. Br J Pharmacol 2000;129:823–834.

    Article  PubMed  CAS  Google Scholar 

Recommended Reading

  1. Cines DB, Pollak ES, Buck CA, Loscalzo J, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527–3561.

    PubMed  CAS  Google Scholar 

  2. O’Rourke ST, Vanhoutte PM. Vascular pharmacology. In: Loscalzo J, Creager MA, Dzau VJ, eds. Vascular Medicine: A Textbook of Vascular Biology and Diseases, 1st ed. Little Brown, Boston, 1992, pp. 133–156.

    Google Scholar 

  3. Stamler JS, Dzau VJ, Loscalzo J. The vascular smooth muscle cell. In: Loscalzo J, Creager MA, Dzau VJ, eds. Vascular Medicine: A Textbook of Vascular Biology and Diseases, 1st ed. Little Brown, Boston, 1992, pp. 79–132.

    Google Scholar 

  4. Pepine CJ, ed. A Symposium: Endothelial Function and Cardiovascular Disease: Potential Mechanisms and Interventions. Amer J Cardiol 1998;82(10A):1S–64S.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York

    Clive Rosendorff MD, PhD, FRCP, FACP, FACC (Professor of Medicine)

  2. VA Medical Center, Bronx, NY

    Clive Rosendorff MD, PhD, FRCP, FACP, FACC (Professor of Medicine)

Authors
  1. Clive Rosendorff MD, PhD, FRCP, FACP, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medicine, Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY

    Clive Rosendorff MD, PhD, FRCP (Professor) (Professor)

  2. Veterans Affairs Medical Center, Bronx, NY

    Clive Rosendorff MD, PhD, FRCP (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Rosendorff, C. (2005). Vascular Function. In: Rosendorff, C. (eds) Essential Cardiology. Humana Press. https://doi.org/10.1007/978-1-59259-918-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-918-9_4

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-370-1

  • Online ISBN: 978-1-59259-918-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation